X-linked lymphoproliferative disease due to XIAP deficiency
X-linked lymphoproliferative disease due to XIAP deficiency
Explore linked clinical trials. Standard reference: MONDO:00103852 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations | Digestive System Diseases, X-linked lymphoproliferative disease due to XIAP deficiency, digestive system disorder, enterocolitis, gastroenteritis, intestinal disorder | Active, not recruiting | Phase 2 | 2026-10-09 | NCT04641442 | |
| Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency | X-linked lymphoproliferative disease due to XIAP deficiency | Recruiting | Phase 1 | 2026-03-27 | NCT07433621 |